S. Buti, M. Riccò, M. D. Chiesa, B. Copercini, G. Tomasello, M. Brighenti and R. Passalacqua, “Oxaliplatin-Induced Hemolytic Anemia during Adjuvant Treatment of a Patient with Colon Cancer: A Case Report,” Anticancer Drugs, Vol. 18, No. 3, 2007, pp. 297-300. doi:10.1097/CAD.0b013e3280102f4b

has been cited by the following article:

• TITLE: Recurrent Oxaliplatin-Induced Immune Hemolytic Anemia by Chemotherapy for Metastatic Colon Cancer: A Case Report

  AUTHORS: Sandrine Oziel-Taieb, Renaud Sabatier, Marine Gilabert, Sylvain Garciaz, Pauline Ries, Slimane Dermeche, Jean-Luc Raoul

  KEYWORDS: Oxaliplatine; Hemolysis; Auto-Immune; Colorectal Cancer

  JOURNAL NAME: Journal of Cancer Therapy, Vol.4 No.1, February 17, 2013

  ABSTRACT: We report herein the case of a 55-year-old man who presented an acute hemolysis following a 6th cycle of FOLFOX regimen for a metastatic colorectal cancer; this patient had previously received 12 cycles in an adjuvant setting. He had presented attenuated signs during the previous cycle. This corresponded to an oxaliplatin-induced immune hemolytic anemia. This unfrequent side effect of oxaliplatin needs to be known in order to avoid severe complications.